Discontinuation of imatinib therapy after achieving a molecular response [3]

Jorge Cortes, Susan O'Brien, Hagop Kantarjian

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2204-2205
Number of pages2
JournalBlood
Volume104
Issue number7
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Discontinuation of imatinib therapy after achieving a molecular response [3]. / Cortes, Jorge; O'Brien, Susan; Kantarjian, Hagop.

In: Blood, Vol. 104, No. 7, 01.10.2004, p. 2204-2205.

Research output: Contribution to journalLetter

Cortes, Jorge ; O'Brien, Susan ; Kantarjian, Hagop. / Discontinuation of imatinib therapy after achieving a molecular response [3]. In: Blood. 2004 ; Vol. 104, No. 7. pp. 2204-2205.
@article{7f4ea76f51734b6ba56fc9874c07ae5e,
title = "Discontinuation of imatinib therapy after achieving a molecular response [3]",
author = "Jorge Cortes and Susan O'Brien and Hagop Kantarjian",
year = "2004",
month = "10",
day = "1",
doi = "10.1182/blood-2004-04-1335",
language = "English (US)",
volume = "104",
pages = "2204--2205",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Discontinuation of imatinib therapy after achieving a molecular response [3]

AU - Cortes, Jorge

AU - O'Brien, Susan

AU - Kantarjian, Hagop

PY - 2004/10/1

Y1 - 2004/10/1

UR - http://www.scopus.com/inward/record.url?scp=4644341516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644341516&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-04-1335

DO - 10.1182/blood-2004-04-1335

M3 - Letter

C2 - 15377577

AN - SCOPUS:4644341516

VL - 104

SP - 2204

EP - 2205

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -